iRhythm Holdings (IRTC) Dropped Despite Posting Beat-And-Raise Results
Key takeaways
- Small-cap stocks delivered mixed results in the quarter as the market favored value stocks over growth.
- In its first-quarter 2026 investor letter, Carillon Eagle Small Cap Growth Fund highlighted IRhythm Holdings, Inc.
- Carillon Eagle Small Cap Growth Fund stated the following regarding IRhythm Holdings, Inc.
A copy of the letter can be downloaded here. Small-cap stocks delivered mixed results in the quarter as the market favored value stocks over growth. The Russell 2000 Growth Index fell 2.82% in the quarter, while the Russell 2000® Value Index increased 4.96%. The first quarter saw equity market volatility due to Iran strikes, boosting energy prices. The firm is optimistic that the turbulence in the market will be short-lived, with improved valuations and potential positive developments from de-escalation in the Middle East. In addition, please check the Fund's top five holdings to know its best picks in 2026.
In its first-quarter 2026 investor letter, Carillon Eagle Small Cap Growth Fund highlighted IRhythm Holdings, Inc. (NASDAQ:IRTC). IRhythm Holdings, Inc. (NASDAQ:IRTC) is a digital healthcare company that provides Zio ambulatory cardiac monitoring services. The company, previously known as iRhythm Technologies, Inc., changed its name to iRhythm Holdings, Inc. in January 2026. On June 24, 2026, IRhythm Holdings, Inc. (NASDAQ:IRTC) closed at $112.47 per share. One-month return of IRhythm Holdings, Inc. (NASDAQ:IRTC) was -2.72%, and its shares lost 26.34% over the past 52 weeks. IRhythm Holdings, Inc. (NASDAQ:IRTC) has a market capitalization of $3.7 billion.
Carillon Eagle Small Cap Growth Fund stated the following regarding IRhythm Holdings, Inc. (NASDAQ:IRTC) in its Q1 2026 investor letter: